Prediction of response to immune modifying therapy for patients with chronic hepatitis B using hepatitis B surface antigen levels

Vincent Rijckborst

Research output: Types of ThesisDoctoral ThesisInternal

20 Downloads (Pure)
Original languageUndefined/Unknown
Awarding Institution
  • Erasmus University Rotterdam
Supervisors/Advisors
  • Janssen, HLA, Supervisor
Publisher
Publication statusPublished - 2011

Research programs

  • EMC MM-04-20-02-A

Cite this